These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 28878291
1. MAP kinase-interacting serine/threonine kinase 2 promotes proliferation, metastasis, and predicts poor prognosis in non-small cell lung cancer. Guo Z, Peng G, Li E, Xi S, Zhang Y, Li Y, Lin X, Li G, Wu Q, He J. Sci Rep; 2017 Sep 06; 7(1):10612. PubMed ID: 28878291 [Abstract] [Full Text] [Related]
2. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway. Bai Y, Liu X, Qi X, Liu X, Peng F, Li H, Fu H, Pei S, Chen L, Chi X, Zhang L, Zhu X, Song Y, Wang Y, Meng S, Jiang T, Shao S. EBioMedicine; 2019 Apr 06; 42():311-325. PubMed ID: 30922965 [Abstract] [Full Text] [Related]
3. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway. Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q. J Cell Biochem; 2014 Jan 06; 115(1):81-92. PubMed ID: 23904219 [Abstract] [Full Text] [Related]
4. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer. Lu J, Zang H, Zheng H, Zhan Y, Yang Y, Zhang Y, Liu S, Feng J, Wen Q, Long M, Fan S. PLoS One; 2020 Jan 06; 15(2):e0227768. PubMed ID: 32023262 [Abstract] [Full Text] [Related]
7. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients. Zhang X, Zhou H, Zhang Y, Cai L, Jiang G, Li A, Miao Y, Li Q, Qiu X, Wang E. Oncotarget; 2017 Jun 13; 8(24):38863-38875. PubMed ID: 28418919 [Abstract] [Full Text] [Related]
11. Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail. Deng M, Liu B, Zhang Z, Chen Y, Wang Y, Wang X, Lv Q, Yang X, Hou K, Che X, Qu X, Liu Y, Zhang Y, Hu X. Cancer Sci; 2020 Sep 13; 111(9):3210-3221. PubMed ID: 32519357 [Abstract] [Full Text] [Related]
14. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer. Guan ZB, Cao YS, Li Y, Tong WN, Zhuo AS. Cancer Biomark; 2018 Feb 14; 21(3):557-563. PubMed ID: 29286919 [Abstract] [Full Text] [Related]
16. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Sun M, Liu XH, Wang KM, Nie FQ, Kong R, Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, Chen JF, Zhang EB, De W, Wang ZX. Mol Cancer; 2014 Mar 21; 13():68. PubMed ID: 24655544 [Abstract] [Full Text] [Related]
17. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer. Yan M, Sun L, Li J, Yu H, Lin H, Yu T, Zhao F, Zhu M, Liu L, Geng Q, Kong H, Pan H, Yao M. J Exp Clin Cancer Res; 2019 Nov 27; 38(1):478. PubMed ID: 31775888 [Abstract] [Full Text] [Related]
19. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity. Song P, Song B, Liu J, Wang X, Nan X, Wang J. Clin Transl Oncol; 2021 Apr 27; 23(4):892-901. PubMed ID: 32974862 [Abstract] [Full Text] [Related]